When did ClearPoint Neuro report Q4 2024 earnings?

ClearPoint Neuro (CLPT) reported Q4 2024 earnings on February 26, 2025 after market close.

What were ClearPoint Neuro's Q4 2024 revenue and EPS?

ClearPoint Neuro reported revenue of $7.8M and diluted EPS of $-0.20 for Q4 2024.

Did ClearPoint Neuro beat estimates in Q4 2024?

Revenue missed the consensus estimate of $8.2M by $458.7K. EPS missed the consensus estimate of $-0.15 by $0.05.

Where can I find ClearPoint Neuro's Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-027934) directly on SEC EDGAR. The filing index links above go to sec.gov.

ClearPoint Neuro CLPT Q4 2024 Annual earnings

Reported February 26, 2025 · After market close

Revenue$7.8MMiss by $458.7K Diluted EPS-$0.20Miss by $0.05

Revenue estimate$8.2M

EPS estimate-$0.15

Next report

Aug 11, 2026 (in a month)

Revenue estimate$12.7M

EPS estimate-$0.27

Financials

Q4 2024

Income statement

See full

Revenue$7.8M+14.1%

Gross profit$4.8M+18.7%

Operating income-$5.6M-19.8%

Net income-$5.4M-16.6%

EPS (diluted)-$0.20-5.3%

Balance sheet

See full

Cash & equivalents$20.1M-13.1%

Total debt$3.6M-74.4%

Total equity$25.4M+19.9%

Total assets$39.2M-8.1%

Cash flow

See full

Operating cash flow-$1.2M-6.3%

CapEx$263.0K+1,152%

Free cash flow-$1.5M-26.6%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$424.25M+154%

Enterprise value$407.72M+158%

P/S13.5×+6.5×

Profitability

See full

Gross margin60.9%+4.1pp

Operating margin-62.9%-15.6pp

Net margin-60.3%-15.5pp

FCF margin-29.4%-10.0pp

Returns & leverage

See full

Return on equity-81.2%+5.9pp

Debt / equity0.1×-0.5×

Current ratio3.2×-1.6×

Segments

By product

See full

Biologics And Drug Delivery$4.2M+4.3%

Biologics And Drug Delivery Services And License Fees$2.9M-11.7%

Neurosurgery Navigation And Therapy$2.9M—

Biologics And Drug Delivery Disposable Products$1.3M+73.9%

Capital Equipment And Software$614.0K-12.2%

Versus estimates

Revenue

Q1 2026$12.1MBeat by $161.3K Q4 2025$10.4MBeat by $350.0K Q3 2025$8.9MMiss by $1.5M Q2 2025$9.2MMiss by $585.0K Q1 2025$8.5MMiss by $681.7K

Q4 2024$7.8MMiss by $458.7K

Diluted EPS

Q1 2026-$0.32Miss by $0.04 Q4 2025-$0.27Miss by $0.05 Q3 2025-$0.21Miss by $0.01 Q2 2025-$0.21Miss by $0.01 Q1 2025-$0.22Miss by $0.07

Q4 2024-$0.20Miss by $0.05

Ask the moment ClearPoint Neuro reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did ClearPoint Neuro report Q4 2024 earnings?: ClearPoint Neuro (CLPT) reported Q4 2024 earnings on February 26, 2025 after market close.
What were ClearPoint Neuro's Q4 2024 revenue and EPS?: ClearPoint Neuro reported revenue of $7.8M and diluted EPS of $-0.20 for Q4 2024.
Did ClearPoint Neuro beat estimates in Q4 2024?: Revenue missed the consensus estimate of $8.2M by $458.7K. EPS missed the consensus estimate of $-0.15 by $0.05.
Where can I find ClearPoint Neuro's Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-027934) directly on SEC EDGAR. The filing index links above go to sec.gov.